Literature DB >> 24189415

Drinkable preparation of Theracurmin exhibits high absorption efficiency--a single-dose, double-blind, 4-way crossover study.

Tatsuya Morimoto1, Yoichi Sunagawa, Yasufumi Katanasaka, Sae Hirano, Masatoshi Namiki, Yuichi Watanabe, Hidetoshi Suzuki, Osamu Doi, Kiyomi Suzuki, Miyuki Yamauchi, Tsunehiro Yokoji, Eriko Miyoshi-Morimoto, Yoshihiko Otsuka, Tomoko Hamada, Atsushi Imaizumi, Yuji Nonaka, Takashi Fuwa, Takanori Teramoto, Hideaki Kakeya, Hiromichi Wada, Koji Hasegawa.   

Abstract

Curcumin has various biological activities including antioxidant and antiinflammatory actions, and alcohol detoxification. However, because of its poor absorption efficiency, it is difficult for orally administered curcumin to reach blood levels sufficient to realize its bioactivities. We have generated capsules and tablets containing Theracurmin, a highly absorptive curcumin. In addition, we recently created a drinkable preparation of Theracurmin. To evaluate the absorption efficiency of this type of curcumin, we performed a single-dose, double-blind, 4-way crossover study. We compared plasma curcumin levels after the administration of Theracurmin beverage and 3 other drinkable types of curcumin sold in Japan. Twenty-four healthy subjects (male/female=13/11, age: 23-32) were administered with these 4 drinkable preparations of curcumin. The area under the blood concentration-time curve at 0-8 h was found to be 1.5 to 4.0-fold higher with Theracurmin than with the other 3 kinds of curcumin beverage. Moreover, maximal plasma curcumin concentrations (0-8 h) of Theracurmin were 1.8 to 3.8 times higher than those of the other 3 curcumin beverages. These data indicate that our newly prepared Theracurmin beverage exhibits a much better absorption efficiency than other kinds of curcumin beverage sold in Japan.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24189415     DOI: 10.1248/bpb.b13-00150

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  A Realistic View on "The Essential Medicinal Chemistry of Curcumin".

Authors:  Fatemeh Bahadori; Mutlu Demiray
Journal:  ACS Med Chem Lett       Date:  2017-09-14       Impact factor: 4.345

2.  Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects.

Authors:  Hyewon Chung; Seo Hyun Yoon; Joo-Youn Cho; Hee Kyung Yeo; Dongseong Shin; Ji-Young Park
Journal:  Int J Clin Pharmacol Ther       Date:  2021-10       Impact factor: 0.976

3.  Pancreatic cancer: Current status and Challenges.

Authors:  Amanda R Muñoz; Divya Chakravarthy; Jingjing Gong; Glenn A Halff; Rita Ghosh; Addanki P Kumar
Journal:  Curr Pharmacol Rep       Date:  2017-10-11

Review 4.  The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis.

Authors:  Kok-Yong Chin
Journal:  Drug Des Devel Ther       Date:  2016-09-20       Impact factor: 4.162

5.  Curcumin plays a synergistic role in combination with HSV-TK/GCV in inhibiting growth of murine B16 melanoma cells and melanoma xenografts.

Authors:  Hong Li; Haiyan Du; Guangxian Zhang; Yingya Wu; Pengxiang Qiu; Jingjing Liu; Jing Guo; Xijuan Liu; Lingling Sun; Biaoyan Du; Yuhui Tan
Journal:  PeerJ       Date:  2019-09-20       Impact factor: 2.984

6.  The fallacy of enzymatic hydrolysis for the determination of bioactive curcumin in plasma samples as an indication of bioavailability: a comparative study.

Authors:  Sidney J Stohs; C Y O Chen; Harry G Preuss; Sidhartha D Ray; Luke R Bucci; Jin Ji; Kevin J Ruff
Journal:  BMC Complement Altern Med       Date:  2019-11-04       Impact factor: 3.659

Review 7.  Current status of top 10 nutraceuticals used for Knee Osteoarthritis in India.

Authors:  Raju Vaishya; Amit Kumar Agarwal; Amish Shah; Vipul Vijay; Abhishek Vaish
Journal:  J Clin Orthop Trauma       Date:  2018-07-20

Review 8.  Dietary Curcumin: Correlation between Bioavailability and Health Potential.

Authors:  Michele Dei Cas; Riccardo Ghidoni
Journal:  Nutrients       Date:  2019-09-08       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.